The Protein Chemistry and Mass Spectrometry ('Proteomics') Core will be under the administration of the Buck Institute's Chemistry Program whose director is Dr. Gibson. Dr. Gibson has over 20 years experience in mass spectrometry and the analysis of proteins and other macromolecules. In the last seven years, this group has carried out extensive studies in mitochondrial proteomics as well as developing new methods to study posttranslational modifications such as 3-nitrotyrosine, phosphorylation and cysteine oxidation. The proteomics facilities in the Core include extensive mass spectrometry, chromatography, and protein chemistry components that are well suited to provide the expertise and methodology needed to carry out the protein chemistry experiments described in Projects 1-3. The resources and knowledge of the Core staff include methods for mitochondrial proteomics, protein identification, chemistry and quantitation, Moreover, methods have been described for the rapid isolation and analysis of large complexes (e.g., mitochondrial electron transport chain, or ETC), and the analysis of protein posttranslational modifications (PTMs), including oxidative damage, protein phosphorylation, and changes in subunit stoichiometries. Therefore, our aims for this Core are to work closely with the PL's of the individual Projects to provide detailed analysis of proteins, i.e., mitochondrial OXPHOS complexes I-V, p53 and tau as well as other proteins, and changes they undergo in response to the manipulation of genes/enzymes that affect the overall redox status, or 'oxidative stress'of the various age-related disease cell and/or animal model systems.
The specific aims of the Proteomics Core in relation to the three Projects in this Program Project are: Andersen, Project 1: We will examine in detail both oxidative damage (both reversible and irreversible) and changes in phosphorylation among the 46 subunits of mitochondrial Complex I (and possibly other ETC complexes and mitochondrial proteins) that accompany acute and/or chronic depletion of glutathione pools in an transgenic anti-GCLmouse and a rat dopaminergic N27 cell line. Campisi and Benz, Project 2: We will examine changes in p53 phosphorylation and cysteinyl redox status (i.e., glutathionylation, cysteic acid, etc.) in human and mouse epithelial fibroblasts (MEFs) when SOD2, glutathione and p53 expression levels have been manipulated and correlated to changes in either p53 levels or DNA binding. Melov Project 3: We will examine changes in the phosphorylation state of tau in a constituitive and, at later stages, an inducible sod2 nullizygous mouse model as a consequence of age and oxidative stress.

National Institute of Health (NIH)
National Institute on Aging (NIA)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Buck Institute for Age Research
United States
Zip Code
Leonoudakis, Dmitri; Rane, Anand; Angeli, Suzanne et al. (2017) Anti-Inflammatory and Neuroprotective Role of Natural Product Securinine in Activated Glial Cells: Implications for Parkinson's Disease. Mediators Inflamm 2017:8302636
Chinta, Shankar J; Woods, Georgia; Rane, Anand et al. (2015) Cellular senescence and the aging brain. Exp Gerontol 68:3-7
Siddiqui, Almas; Bhaumik, Dipa; Chinta, Shankar J et al. (2015) Mitochondrial Quality Control via the PGC1?-TFEB Signaling Pathway Is Compromised by Parkin Q311X Mutation But Independently Restored by Rapamycin. J Neurosci 35:12833-44
Velarde, Michael C; Demaria, Marco; Melov, Simon et al. (2015) Pleiotropic age-dependent effects of mitochondrial dysfunction on epidermal stem cells. Proc Natl Acad Sci U S A 112:10407-12
Laberge, Remi-Martin; Sun, Yu; Orjalo, Arturo V et al. (2015) MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nat Cell Biol 17:1049-61
Lieu, Christopher A; Dewey, Colleen M; Chinta, Shankar J et al. (2014) Lithium prevents parkinsonian behavioral and striatal phenotypes in an aged parkin mutant transgenic mouse model. Brain Res 1591:111-7
Blaschko, Sarah D; Chi, Thomas; Miller, Joe et al. (2013) Strontium substitution for calcium in lithogenesis. J Urol 189:735-9
Flynn, James M; O'Leary, Monique N; Zambataro, Christopher A et al. (2013) Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell 12:851-62
Brand, M D; Orr, A L; Perevoshchikova, I V et al. (2013) The role of mitochondrial function and cellular bioenergetics in ageing and disease. Br J Dermatol 169 Suppl 2:1-8
Lieu, Christopher A; Chinta, Shankar J; Rane, Anand et al. (2013) Age-related behavioral phenotype of an astrocytic monoamine oxidase-B transgenic mouse model of Parkinson's disease. PLoS One 8:e54200

Showing the most recent 10 out of 77 publications